SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001062993-22-008073
Filing Date
2022-03-17
Accepted
2022-03-17 17:33:08
Documents
1
Period of Report
2022-03-15

Document Format Files

Seq Description Document Type Size
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.html 4  
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.xml 4 3079
  Complete submission text file 0001062993-22-008073.txt   4329
Mailing Address
Business Address
ENLOE J DAVID JR (Reporting) CIK: 0001201526 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36329 | Film No.: 22750037

Mailing Address 1 E. UWCHLAN AVE, SUITE 112 EXTON PA 19341
Business Address 1 E. UWCHLAN AVE, SUITE 112 EXTON PA 19341 770-534-8239
Recro Pharma, Inc. (Issuer) CIK: 0001588972 (see all company filings)

IRS No.: 261523233 | State of Incorp.: PA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations